On September 25, Glonhu announced that in the 2024 fiscal year, the group recorded total revenue of approximately 0.748 billion Hong Kong dollars, an increase of 2.9% compared to the 2023 fiscal year. The profit recorded in 2024 was approximately 35.2 million Hong Kong dollars (2023 fiscal year: 55.7 million Hong Kong dollars), a decrease of approximately 20.5 million Hong Kong dollars, or 36.8%. Earnings per share were 5.08 Hong Kong cents.
The decline in annual profits was mainly due to a decrease in operating profit margins, a significant increase in depreciation and amortization, as well as the write-off of other intangible assets, and the deduction of a one-time profit related to the confirmation of guaranteed surplus financial assets. The increase in total revenue was mainly due to the growth in enterprise medical care solutions business and clinical medical services revenue, especially the increase in revenue contributed by the new imaging center opened over the past year.
